Global Oncology Biosimilars Market to grow at a CAGR of 31.76% during the period 2016-2020

Press Release   •   May 25, 2016 16:25 EDT

Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting. 

Check Complete Report @

MarketIntelReports analysts forecast the Global oncology biosimilars market to grow at a CAGR of 31.76% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global oncology biosimilars market for the period 2016-2020. To calculate the market size, the report considers revenue generated from the sales of biosimilars used to treat cancer.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

MarketIntelReports report, Global Oncology Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Ask for a Sample Brochure, if you want to know more @

Key vendors

  • Biocon
  • Celltrion
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • Hospira
  • Mylan
  • Sandoz

Other prominent vendors

  • AbbVie
  • Allergan
  • Amgen
  • AstraZeneca
  • Baxter
  • Biogen
  • BioXpress Therapeutics
  • Boehringer Ingelheim
  • Cipla
  • Coherus BioSciences
  • Coherus BioSciences
  • Daiichi Sankyo
  • Emcure Pharmaceuticals
  • GlaxoSmithKline (GSK)
  • Intas Pharmaceuticals
  • Merck
  • Pfizer
  • Sanofi
  • 3SBio
  • Wockhardt

Market driver

  • Rise in number of patent expiries
  • For a full, detailed list, view our report

Market challenge

  • Risks related to failure of drugs in the market
  • For a full, detailed list, view our report

Market trend

  • Emergence of biosimilars
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Order a copy of Global Oncology Biosimilars Market Report @

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Contact us:

Mayur S

Sales Manager
2711 Centerville Road, Suite 400,
United States
Telephone: 1-302-684-6088

About us:

MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.

A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.

MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.

MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.